Liu_2020_Ann.Hematol_99_2343

Reference

Title : LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia - Liu_2020_Ann.Hematol_99_2343
Author(s) : Liu W , Burger JA , Xu J , Tang Z , Toruner G , Khanlari M , Medeiros LJ , Tang G
Ref : Ann Hematol , 99 :2343 , 2020
Abstract : Liu_2020_Ann.Hematol_99_2343
ESTHER : Liu_2020_Ann.Hematol_99_2343
PubMedSearch : Liu_2020_Ann.Hematol_99_2343
PubMedID: 32833105

Related information

Citations formats

Liu W, Burger JA, Xu J, Tang Z, Toruner G, Khanlari M, Medeiros LJ, Tang G (2020)
LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia
Ann Hematol 99 :2343

Liu W, Burger JA, Xu J, Tang Z, Toruner G, Khanlari M, Medeiros LJ, Tang G (2020)
Ann Hematol 99 :2343